Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR | P00533 | 1/20 | 0.41 |
| ▸ | CA12 | O43570 | 2/20 | 0.39 |
| ▸ | CA1 | P00915 | 2/20 | 0.39 |
| ▸ | CA2 | P00918 | 2/20 | 0.39 |
| ▸ | CA9 | Q16790 | 2/20 | 0.39 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.39 |
| ▸ | GABRA1 | P14867 | 3/20 | 0.38 |
| ▸ | GABRG2 | P18507 | 3/20 | 0.38 |
| ▸ | GABRB3 | P28472 | 3/20 | 0.38 |
| ▸ | GABRA3 | P34903 | 3/20 | 0.38 |
| ▸ | GABRA2 | P47869 | 3/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.37 |
| ▸ | ELANE | P08246 | 1/20 | 0.36 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.36 |
| ▸ | GABRA4 | P48169 | 2/20 | 0.36 |
| ▸ | GABRA6 | Q16445 | 2/20 | 0.36 |
| ▸ | GABRP | O00591 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27389488 | 0.91 | ALDH1A1 (0.37) | EGFRCA12CA1CA2CA9 | |
| SCHEMBL28401369 | 0.91 | ALDH1A1 (0.37) | EGFRCA12CA1CA2CA9 | |
| SCHEMBL828860 | 0.91 | ALDH1A1 (0.37) | EGFRCA12CA1CA2CA9 | |
| SCHEMBL828474 | 0.91 | ALDH1A1 (0.37) | EGFRCA12CA1CA2CA9 | |
| SCHEMBL28703662 | 0.88 | EGFR (0.38) | EGFRCA12CA1CA2CA9 | |
| SCHEMBL6350428 | 0.88 | CYP2C9 (0.41) | EGFRCA12CA1CA2CA9 | |
| SCHEMBL18069231 | 0.83 | EGFR (0.48) | EGFRCA12CA1CA2CA9 | |
| SCHEMBL28603978 | 0.83 | SMN1; SMN2 (0.52) | EGFRCYP2C9CYP2C19NPSR1HSD17B10 | |
| SCHEMBL9618204 | 0.83 | ALDH1A1 (0.38) | EGFRCA12CA1CA2CA9 | |
| SCHEMBL28409328 | 0.81 | CFTR (0.38) | EGFRCA12CA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1567470-B1 | HYDROGENATION OF BENZENE POLYCARBOXYLIC ACIDS OR DERIVATIVES THEREOF | EXXONMOBIL CHEM PATENTS INC (US) | 2013-06-05 | — | — | EP | claimed |
| US-7595420-B2 | Hydrogenation of benzene polycarboxylic acids or derivatives thereof | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2009-09-29 | — | — | US | claimed |
| US-20060247461-A1 | Hydrogenation of benzene polycarboxylic acids or derivatives thereof | EXXONMOBIL CHEMICAL PATENTS INC. | 2006-11-02 | — | — | US | claimed |
| US-10017448-B2 | Process for hydrogenation of benzenepolycarboxylic acids and derivatives thereof | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2018-07-10 | — | — | US | disclosed |
| US-20170291867-A1 | Improved Process for Hydrogenation of Benzenepolycarboxylic Acids and Derivatives Thereof | EXXONMOBIL CHEMICAL PATENTS INC. | 2017-10-12 | — | — | US | disclosed |
| EP-1567470-B1 | HYDROGENATION OF BENZENE POLYCARBOXYLIC ACIDS OR DERIVATIVES THEREOF | EXXONMOBIL CHEM PATENTS INC (US) | 2013-06-05 | — | — | EP | disclosed |
| US-8203017-B2 | Hydrogenation of benzene polycarboxylic acids or derivatives thereof | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2012-06-19 | — | — | US | disclosed |
| US-8143438-B2 | Hydrogenation processes | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2012-03-27 | — | — | US | disclosed |
| US-20110112322-A1 | Hydrogenation of Benzene Polycarboxylic Acids or Derivatives Thereof | EXXONMOBIL CHEMICAL PATENTS INC. | 2011-05-12 | — | — | US | disclosed |
| US-20110082311-A1 | Hydrogenation Processes | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY | 2011-04-07 | — | — | US | disclosed |
| US-7893295-B2 | Hydrogenation of benzene polycarboxylic acids or derivatives thereof | EXXON MOBIL CHEMICAL PATENTS INC. (US) | 2011-02-22 | — | — | US | disclosed |
| US-6888021-B2 | Hydrogenation of benzenepolycarboxylic acids or derivatives thereof using a catalyst containing macropores | BASF AKTIENGESELLSCHAFT (DE) | 2005-05-03 | — | — | US | disclosed |
| US-20040199033-A1 | Method for hydrogenating organic compounds by means of ru/sio2 catalysts | BASF AKTIENGESELLSCHAFT (DE) | 2004-10-07 | — | — | US | disclosed |
| WO-2004046076-A2 | HYDROGENATION CATALYST, PREPARATION THEREOF AND HYDROGENATION PROCESSES USING THIS CATALYST | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2004-06-03 | — | — | WO | disclosed |
| EP-1314714-A2 | Method for hydrogenating benzene polycarboxylic acids or derivatives thereof by using a catalyst containing macropores | BASF AKTIENGESELLSCHAFT (DE) | 2003-05-28 | — | — | EP | disclosed |
| EP-1042273-B1 | METHOD FOR HYDROGENATING BENZENE POLYCARBOXYLIC ACIDS OR DERIVATIVES THEREOF BY USING A CATALYST CONTAINING MACROPORES | BASF AG (DE) | 2003-05-07 | — | — | EP | disclosed |
| US-20020019559-A1 | Hydrogenation of benzenepolycarboxylic acids or derivatives thereof using a catalyst containing macropores | BRUNNER MELANIE (DE) | 2002-02-14 | — | — | US | disclosed |
| US-6284917-B1 | Method for hydrogenating benzene polycarboxylic acids or derivatives thereof by using a catalyst containing macropores | BASF AKTIENGESELLSCHAFT (DE) | 2001-09-04 | — | — | US | disclosed |
| EP-1042273-A1 | METHOD FOR HYDROGENATING BENZENE POLYCARBOXYLIC ACIDS OR DERIVATIVES THEREOF BY USING A CATALYST CONTAINING MACROPORES | BASF AKTIENGESELLSCHAFT (DE) | 2000-10-11 | — | — | EP | disclosed |
| WO-1999032427-A1 | METHOD FOR HYDROGENATING BENZENE POLYCARBOXYLIC ACIDS OR DERIVATIVES THEREOF BY USING A CATALYST CONTAINING MACROPORES | BASF AKTIENGESELLSCHAFT (DE) | 1999-07-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110082311-A1 | Hydrogenation Processes | HAO2, HVCN1, AOC3 | EGFR 2711/4885CA12 1004/4885CA1 502/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.